EUCTR2011-001642-14-GB进行中（未招募）1 期
The effects of subcutaneous insulin detemir on glucose flux, pharmacokinetics and brain function in type one diabetes - The effects of insulin detemir in type 1 diabetes
niversity of Surrey0 个研究点目标入组 16 人开始时间: 2011年4月27日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Informed consent obtained before any trial-related activities. 2. Type 1 diabetes according to clinical judgement. 3. Duration of Type 1 diabetes greater than 12 months. 4. Current treatment basal bolus or biphasic insulin regimes. 5. Age greater than 18 years. 6. BMI of less than 35. 7. HbA1c of greater or equal to 5.5% and less than 9%. 8. Able and willing to complete the trial
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Proliferative retinopathy that has required acute treatment within last three months. 2. Impaired hepatic or renal function as judged by the investigator. 3. Cardiac problems as judged by the investigator. 4. Uncontrolled hypertension. ( BP greater than 160/90) 5. Mental incapacity. 6. Pregnancy. 7. Known or suspected allergy to trial products. 8. Any other condition that the investigator feels would interfere with the trial participation.
研究者
相似试验
进行中（未招募）
1 期
A comparison of the effects of insulin Detemir with insulin Glargine on weight gain in female adolescents and young adults with Type 1 Diabetes (T1D) on a basal bolus regime - A comparison of Insulins Detemir and Glargine in Girls with DiabetesMedDRA version: 9.1 Level: LLT Classification code 10045228 Term: Type I diabetes mellitusType 1 diabetesEUCTR2007-004144-74-GBCambridge University Hospitals NHS Foundation Trust97
已完成
3 期
Determir versus Glargine for weight gain in adolescents with type 1 diabetesTopic: Medicines for Children Research Network, Diabetes Research NetworkSubtopic: Type 1, All DiagnosesDisease: All Diseases, Insulin switch, Metabolic, PaediatricNutritional, Metabolic, EndocrineType 1 diabetesISRCTN49492872Cambridge University Hospitals NHS Foundation Trust (UK)97
进行中（未招募）
1 期
The effect of insulin detemir in combination with liraglutide and metformin compared to liraglutide and metformin in subjects with type 2 diabetes. A 26-week, randomised, open-label, parallel-group, multicentre, multinational trial with a 26-week extensioType 2 diabetesMedDRA version: 9.1 Level: LLT Classification code 10045242 Term: Type II diabetes mellitusEUCTR2007-005317-19-GBovo Nordisk A/S940
进行中（未招募）
不适用
The effect of insulin detemir in combination with liraglutide and metformin compared to liraglutide and metformin in subjects with type 2 diabetes. A 26-week, randomised, open-label, parallel-group, multicentre, multinational trial with a 26-week extension - NDEUCTR2007-005317-19-ITOVO NORDISK940
进行中（未招募）
1 期
The effect of insulin detemir in combination with liraglutide and metformin compared to liraglutide and metformin in subjects with type 2 diabetes.A 26-week, randomised, open-label, parallel-group, multicentre, multinational trial with a 26-week extensioEUCTR2007-005317-19-FRovo Nordisk A/S940